Jessica L. Coker

Researcher

University of Arkansas for Medical Sciences

faculty

9 h-index 34 pubs 338 cited

Research Areas

Links

ORCID Lab Website Research Group UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Jessica L. Coker's research focuses on maternal and perinatal mental health, with a particular emphasis on postpartum conditions. Her work includes the assessment of patient-reported outcome measures for postpartum depression and anxiety, utilizing established guidelines for instrument selection. She has contributed to the development and validation of tools such as the Stanford Obstetric Recovery Checklist (STORK). Her publications also address broader issues within perinatal psychiatry, including the correlation between postpartum psychosis and SARS-CoV-2 infection, and the impact of the opioid epidemic on this population. Coker has also investigated differential depressive symptom patterns in perinatal women through exploratory factor analysis and has examined the use of continuous fetal monitoring during electroconvulsive therapy. Her scholarship includes 34 publications, with an h-index of 9 and 338 total citations. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Lindsay Ellis Blake, Everett F. Magann, Jarna R Shah, and Michael Mancino.

Metrics

h-index: 9
Publications: 34
Citations: 338

Selected Publications

Impact of substance use and trauma on postpartum readmission rates and hospitalization costs: An observational study (2025) DOI
Peripartum substance use and punitive laws: an update (2025) DOI
High Rates of Probable Posttraumatic Stress Disorder in an Acute Psychiatric Women’s Inpatient Unit: An Opportunity to Improve Diagnosis and Direct Critical Efforts (2025) DOI
122 Association between partner factors on continued substance use among pregnant people with opioid use disorder (2024) DOI
The forgotten: Increasing awareness of late maternal deaths (2023) DOI
A systematic review of patient–reported outcome measures used in maternal postpartum anxiety (2023) DOI
Time to pay attention: an underrecognized casualty of the opioid epidemic (2023) DOI
Detection of differential depressive symptom patterns in a cohort of perinatal women: an exploratory factor analysis using a robust statistics approach (2023) DOI
A Systematic Review of Patient-Reported Outcome Measures to Screen for Maternal Postpartum Anxiety (2022) DOI
Psychiatric participation in US Maternal Mortality Review Committees (2022) DOI
Assessment of Patient-Reported Outcome Measures for Maternal Postpartum Depression Using the Consensus-Based Standards for the Selection of Health Measurement Instruments Guideline (2022) DOI
Cannabis Use is Associated with Depressive Symptoms Among Pregnant Women Receiving Buprenorphine for Opioid Use Disorder (2022) DOI
Postpartum psychosis and SARS-CoV-2 infection: is there a correlation? (2021) DOI
Clearance of buprenorphine during pregnancy and neonatal outcomes (2021) DOI
Peripartum management for women with opioid dependence (2021) DOI